Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study
European Journal of Neurology2021Vol. 28(10), pp. 3348–3359
Citations Over TimeTop 1% of 2021 papers
Verena Rass, Ronny Beer, Alois Josef Schiefecker, Mario Kofler, Anna Lindner, Philipp Mahlknecht, Beatrice Heim, Victoria Limmert, Sabina Sahanic, Alex Pizzini, Thomas Sonnweber, Ivan Tancevski, Christoph Scherfler, Laura Zamarian, Rosa Bellmann‐Weiler, Günter Weiß, Atbin Djamshidian, Stefan Kiechl, Klaus Seppi, Judith Löffler‐Ragg, Bettina Pfausler, Raimund Helbok
Abstract
Despite recovery from the acute infection, neurological symptoms were prevalent at the 3-month follow-up. Above all, smelling disorders were persistent in a large proportion of patients.
Related Papers
- → The Course of Anxiety and Depression in Patients with Breast Cancer and Gynaecological Cancer(2008)70 cited
- → Poststroke Anxiety and Depression: Findings from Saudi Arabia(2016)11 cited
- → Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy(2015)3 cited
- → Prevalence of depression and anxiety among cancer patients in small town in India: Single Centre study(2019)3 cited